Found 4 hits for monomerid = 202490 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM202490
(US9539260, A3 | US9763952, Example A3)Show SMILES O=C(C1CCOCC1)N1CC[C@@H](C1)Oc1ccc2OCCN(c3cncc(c3)S(=O)(=O)N3CCOCC3)c2c1 |r| Show InChI InChI=1S/C27H34N4O7S/c32-27(20-4-10-35-11-5-20)29-6-3-23(19-29)38-22-1-2-26-25(16-22)31(9-14-37-26)21-15-24(18-28-17-21)39(33,34)30-7-12-36-13-8-30/h1-2,15-18,20,23H,3-14,19H2/t23-/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 313 | n/a | n/a | n/a | n/a | n/a | 25 |
NOVARTIS AG
US Patent
| Assay Description Determination of Enzymatic PI3K Alpha and PI3K Delta Isoform Inhibition1.1 Test of Lipid Kinase ActivityThe efficacy of the compounds of examples 1-1... |
US Patent US9539260 (2017)
BindingDB Entry DOI: 10.7270/Q2W37TH1 |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM202490
(US9539260, A3 | US9763952, Example A3)Show SMILES O=C(C1CCOCC1)N1CC[C@@H](C1)Oc1ccc2OCCN(c3cncc(c3)S(=O)(=O)N3CCOCC3)c2c1 |r| Show InChI InChI=1S/C27H34N4O7S/c32-27(20-4-10-35-11-5-20)29-6-3-23(19-29)38-22-1-2-26-25(16-22)31(9-14-37-26)21-15-24(18-28-17-21)39(33,34)30-7-12-36-13-8-30/h1-2,15-18,20,23H,3-14,19H2/t23-/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG
US Patent
| |
US Patent US9763952 (2017)
BindingDB Entry DOI: 10.7270/Q2V40X9Z |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM202490
(US9539260, A3 | US9763952, Example A3)Show SMILES O=C(C1CCOCC1)N1CC[C@@H](C1)Oc1ccc2OCCN(c3cncc(c3)S(=O)(=O)N3CCOCC3)c2c1 |r| Show InChI InChI=1S/C27H34N4O7S/c32-27(20-4-10-35-11-5-20)29-6-3-23(19-29)38-22-1-2-26-25(16-22)31(9-14-37-26)21-15-24(18-28-17-21)39(33,34)30-7-12-36-13-8-30/h1-2,15-18,20,23H,3-14,19H2/t23-/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 313 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG
US Patent
| Assay Description The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and p... |
US Patent US9763952 (2017)
BindingDB Entry DOI: 10.7270/Q2V40X9Z |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM202490
(US9539260, A3 | US9763952, Example A3)Show SMILES O=C(C1CCOCC1)N1CC[C@@H](C1)Oc1ccc2OCCN(c3cncc(c3)S(=O)(=O)N3CCOCC3)c2c1 |r| Show InChI InChI=1S/C27H34N4O7S/c32-27(20-4-10-35-11-5-20)29-6-3-23(19-29)38-22-1-2-26-25(16-22)31(9-14-37-26)21-15-24(18-28-17-21)39(33,34)30-7-12-36-13-8-30/h1-2,15-18,20,23H,3-14,19H2/t23-/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | 25 |
NOVARTIS AG
US Patent
| Assay Description Determination of Enzymatic PI3K Alpha and PI3K Delta Isoform Inhibition1.1 Test of Lipid Kinase ActivityThe efficacy of the compounds of examples 1-1... |
US Patent US9539260 (2017)
BindingDB Entry DOI: 10.7270/Q2W37TH1 |
More data for this Ligand-Target Pair | |